US FDA authorises Merck's Bravecto Chews for emergency use against New World screwworm in dogs
EN
eFeedLink Newsdesk
The emergency use authorisation follows a field study in naturally infested dogs, with EUA-labelled product due to reach US veterinarians by early Q2 2027.
Related Articles
US FDA places 11 foreign seafood firms on import alert over ice glaze short-weighting
29 Oct 2026
US reopens third cattle port at Columbus, New Mexico, under tighter screwworm screening
26 Oct 2026
New Zealand's Cadmus Animal Health raises NZ$8 million for canine periodontal disease programme
15 Oct 2026